Sign in

CIK 0001759138 · Non-accelerated filer<br>Smaller reporting company

Cabaletta Bio, Inc.

Sign in to watch
Ticker
CABA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 759-3100
Business address
2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, 19104
  1. PRE 14A Proxy Proxy Statement (Preliminary)
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. 10-K Report Annual Report
  4. 8-K Event Results of operations · Regulation FD disclosure
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 4 Open-market buy Chief Medical Officer bought 8,800 shares at $2.26 ($19,888)
  16. 4 Open-market buy President, Science & Tech. bought 11,312 shares at $2.19 ($24,763)
  17. 4 Open-market buy Director bought 22,725 shares at $2.21 ($50,322)
  18. 4 Open-market buy Chief Commercial Officer bought 22,170 shares at $2.27 ($50,215)
  19. 4 Open-market buy Director bought 4,405 shares at $2.27 ($9,982)
  20. 4 Open-market buy President & CEO bought 45,000 shares at $2.24 ($100,778)

Page 3 of 23 · 452 filings